ANKRD18CP

Across TCGA pan-cancer cohorts, ANKRD18CP Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated ANKRD18CP data layer compared with 21 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher ANKRD18CP Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ANKRD18CP expression acts as an unfavorable survival marker.

COAD are the cancer types where ANKRD18CP Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	II,III,IV	0.111	0.853	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

ANKRD18CP–COAD (OS)

Open the COAD breakdown →